Nektar Therapeutics
ADENOSINE 2 RECEPTOR ANTAGONISTS

Last updated:

Abstract:

The instant disclosure provides novel adenosine receptor antagonist compounds, compositions, methods of making and methods of using. In a further aspect, a method of treating a subject in need thereof, comprising administering a therapeutically effective amount of any one or more of the compounds described herein. In some embodiments, the subject has cancer and the method is a method of treating cancer.

Status:
Application
Type:

Utility

Filling date:

1 May 2020

Issue date:

28 Jul 2022